Peptide · Approved

Enfuvirtide

An HIV fusion-inhibitor peptide (Fuzeon) that blocks the virus from entering cells.

Key facts

  • Also known as: Fuzeon, T-20
  • Status: Approved
  • Used for: HIV fusion inhibitor
  • Natural counterpart: Derived from HIV’s own gp41 protein (viral, not human).
  • Target enzyme / receptor: HIV-1 gp41 envelope protein (binds the viral fusion machinery)
  • Signalling pathway: Blocks gp41 six-helix-bundle formation → prevents viral–cell membrane fusion
    In plain terms: Physically blocks HIV from fusing with and entering human cells.
  • Crystal / cryo-EM structure: Available  PDB 1AIK ↗

Status & safety

This is an approved medicine — prescription-only in most countries. Only use it under a licensed clinician, obtained through a pharmacy.

Research & clinical studies

Explore the biochemistry and clinical evidence for Enfuvirtide — these open live, date-sorted searches, so they always show the latest.

Read research papers on PubMed ↗

Not medical advice. Chemdu is an educational resource and does not sell, prescribe or supply any peptide. Consult a licensed professional about any medicine or supplement.